Chairpersons :

Shishir Shetty, S. D. Banavali, Anil Sanganeria

Reviewer :

Narayanan Prasad

1. MONARCH 2: Abemaciclib in combination with Fulvestrant in women with HR+/HER2 advanced breast cancer who had progressed while receiving endocrine therapy Author: George W. Sledge Citation: Journal of Clinical Oncology 35, no. 25 (September 2017) 2875-2884

2. MONARCH 3: Abemaciclib as initial therapy for advanced breast cancer Author: Goetz MP Citation: J Clin Oncol. 2017 Nov 10;35(32):3638-3646